These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24289762)

  • 1. Assessment of the consistency among three drug compendia in listing and ranking of drug-drug interactions.
    Nikolić BS; Ilić MS
    Bosn J Basic Med Sci; 2013 Nov; 13(4):253-8. PubMed ID: 24289762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels.
    Ekstein D; Tirosh M; Eyal Y; Eyal S
    Epilepsy Behav; 2015 Mar; 44():218-24. PubMed ID: 25771206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.
    Martins MA; Carlos PP; Ribeiro DD; Nobre VA; César CC; Rocha MO; Ribeiro AL
    Eur J Clin Pharmacol; 2011 Dec; 67(12):1301-8. PubMed ID: 21701882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
    Chao SD; Maibach HI
    Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide analysis of factors associated with medicines compendia publishing.
    Arguello B; Fernandez-Llimos F
    Int J Clin Pharm; 2013 Jun; 35(3):386-92. PubMed ID: 23536106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants.
    Acton EK; Willis AW; Gelfand MA; Kasner SE
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1534-1538. PubMed ID: 31517414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology.
    Barbieri JS; St Claire K; Mostaghimi A; Albrecht J
    JAMA Dermatol; 2019 Mar; 155(3):315-320. PubMed ID: 30673082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.
    Dundar Y; Dodd S; Dickson R; Walley T; Haycox A; Williamson PR
    Health Technol Assess; 2006 Feb; 10(5):iii-iv, ix-145. PubMed ID: 16487455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Consistency of Drug Interaction Information in Drug Labels Among the United States, the United Kingdom, China, Japan, and Korea.
    Jeong S; Kam G; Li J; Lee S; Lee H; Noh Y; Shin JY
    Clin Pharmacol Ther; 2019 Feb; 105(2):505-514. PubMed ID: 29953578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using the British National Formulary effectively.
    Bellerby A; Needham DS
    Nurs Stand; 2016 Sep; 31(4):56-62. PubMed ID: 27654562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of potentially hepatotoxic drugs among major US drug compendia.
    Guo JJ; Wigle PR; Lammers K; Vu O
    Res Social Adm Pharm; 2005 Sep; 1(3):460-79. PubMed ID: 17138490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK).
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Eur J Clin Pharmacol; 2005 Aug; 61(7):531-6. PubMed ID: 16041596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
    Olvey EL; Clauschee S; Malone DC
    Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.
    Grizzle AJ; Horn J; Collins C; Schneider J; Malone DC; Stottlemyer B; Boyce RD
    J Med Internet Res; 2019 Jan; 21(1):e11182. PubMed ID: 30609981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
    Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
    Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lack of consensus on drug interactions: a descriptive analysis of information on interactions in the Laegemiddelkatalog, Medicinfortegnelse and product descriptions].
    Petersen MN; Christensen HR; Kristensen MB
    Ugeskr Laeger; 2005 Aug; 167(35):3286-90. PubMed ID: 16138970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.